Biochemical aspects of dopamine agonists.
D000818:Animals; D001058:Apomorphine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism*; D001933:Brain Stem / Q000378:metabolism; D002531:Cerebellum / Q000378:metabolism; D003342:Corpus Striatum / Q000378:metabolism; D004027:Diencephalon / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D004347:Drug Interactions; D006220:Haloperidol / Q000494:pharmacology*; D008032:Limbic System / Q000378:metabolism; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D011955:Receptors, Drug; D013687:Telencephalon / Q000378:metabolism; D014316:Tritium; D014439:Tyramine / Q000031:analogs & derivatives / Q000096:biosynthesis
D011955:Receptors, Drug; D014316:Tritium; D004295:Dihydroxyphenylalanine; D010293:Pargyline; D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine; D014439:Tyramine